Teladoc Health (NYSE:TDOC – Get Free Report) is anticipated to post its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect Teladoc Health to post earnings of ($0.21) per share and revenue of $639.44 million for the quarter. Individual that wish to listen to the company’s earnings conference call can do so using this link.
Teladoc Health Price Performance
TDOC opened at $11.52 on Monday. The stock has a 50-day moving average price of $10.55 and a 200-day moving average price of $9.47. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm has a market cap of $1.98 billion, a PE ratio of -2.00 and a beta of 1.05. Teladoc Health has a 1 year low of $6.76 and a 1 year high of $15.95.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on TDOC. TD Cowen lowered their price target on Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a research report on Thursday, October 31st. Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Deutsche Bank Aktiengesellschaft lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Piper Sandler reaffirmed an “overweight” rating and issued a $13.00 price target (up previously from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Finally, Barclays lifted their price target on Teladoc Health from $10.00 to $12.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. Thirteen analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Teladoc Health currently has an average rating of “Hold” and an average price target of $11.81.
Insider Activity
In related news, insider Carlos Nueno sold 2,389 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. The trade was a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 0.95% of the company’s stock.
About Teladoc Health
Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Featured Stories
- Five stocks we like better than Teladoc Health
- What Does Downgrade Mean in Investing?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.